| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.99B | 35.13B | 31.86B | 30.36B | 29.35B | 25.90B |
| Gross Profit | 10.52B | 11.02B | 9.93B | 9.87B | 9.72B | 8.71B |
| EBITDA | 2.74B | 2.82B | 2.15B | 2.29B | 3.79B | 3.34B |
| Net Income | 890.00M | 1.09B | 500.00M | 561.00M | 1.61B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 19.62B | 22.48B | 20.45B | 20.14B | 19.57B | 19.28B |
| Cash, Cash Equivalents and Short-Term Investments | 5.15B | 6.46B | 5.36B | 6.01B | 5.93B | 6.16B |
| Total Debt | 1.56B | 1.14B | 1.51B | 1.84B | 1.45B | 1.82B |
| Total Liabilities | 10.31B | 12.50B | 10.89B | 10.44B | 9.80B | 10.41B |
| Stockholders Equity | 9.30B | 9.98B | 9.56B | 9.71B | 9.77B | 8.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.88B | 686.00M | 800.00M | 1.47B | 2.21B |
| Operating Cash Flow | 0.00 | 3.58B | 1.88B | 1.68B | 2.20B | 2.65B |
| Investing Cash Flow | 0.00 | -1.61B | -1.53B | -1.35B | -1.38B | -1.86B |
| Financing Cash Flow | 0.00 | -1.01B | -991.00M | -249.00M | -1.05B | -1.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥19.77B | 7.28 | ― | 3.47% | 4.22% | 27.56% | |
72 Outperform | ¥25.86B | 14.81 | ― | 4.01% | -1.18% | -12.01% | |
65 Neutral | ¥24.12B | 22.17 | ― | 2.85% | 10.25% | 115.25% | |
64 Neutral | ¥17.91B | 10.44 | ― | 3.81% | 9.96% | 252.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Sprix Inc. reported a significant increase in its financial performance for the nine months ending June 30, 2025, with net sales rising by 9.4% year-on-year to 24,915 million yen. The company’s operating profit surged by 394.6% to 761 million yen, and profit attributable to owners of the parent increased to 417 million yen, reflecting a strong recovery and growth trajectory. The company maintains a stable financial position with a slight increase in equity ratio, and it has not revised its dividend forecast, indicating confidence in its ongoing financial health.